Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath System brings robotic-assisted precision to percutaneous coronary interventions. Corindus’s next-generation CorPath GRX System is advancing the field of robotic interventions, offering improvements in procedural control for the physician, workflow for the technologist, radiation protection for physicians and the potential to reduce radiation exposure for staff and patients.
Corindus recently strengthened its operational and clinical teams to support expansion of the FDA-cleared CorPath GRX System and its commitment to conducting cutting-edge vascular robotics research. New leadership includes medical device veteran, Mark Toland, President & CEO and interventional cardiology thought leaders J. Aaron Grantham, MD, Chief Medical Officer and Marty Leon, MD.